Ginkgo Bioworks Holdings Inc

NEW
NYSE:DNA (USA)  
$ 7 +0.54 (+8.36%) 03:45 PM EST
At Loss
P/B:
0.53
Market Cap:
$ 406.24M
Enterprise V:
$ 278.15M
Volume:
1.23M
Avg Vol (2M):
1.82M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
1.23M
At Loss
Avg Vol (2M):
1.82M

Business Description

Ginkgo Bioworks Holdings Inc
NAICS : 541714 SIC : 2836
ISIN : US37611X1000
Description
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Name Current Vs Industry Vs History
Cash-To-Debt 1.2
Equity-to-Asset 0.52
Debt-to-Equity 0.65
Debt-to-EBITDA -0.97
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.28
Distress
Grey
Safe
Beneish M-Score -2.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.62
Quick Ratio 5.62
Cash Ratio 5.24
Days Inventory 0.48
Days Sales Outstanding 33.83
Days Payable 146.2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.5
Shareholder Yield % -8.72

Financials (Next Earnings Date:2025-05-09 Est.)

DNA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:DNA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Ginkgo Bioworks Holdings Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 227.043
EPS (TTM) ($) -10.68
Beta 1.26
3-Year Sharpe Ratio -0.77
3-Year Sortino Ratio -0.93
Volatility % 103.11
14-Day RSI 28.51
14-Day ATR ($) 1.102738
20-Day SMA ($) 9.523
12-1 Month Momentum % -71.05
52-Week Range ($) 5.26 - 48
Shares Outstanding (Mil) 58.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ginkgo Bioworks Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Ginkgo Bioworks Holdings Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Ginkgo Bioworks Holdings Inc Frequently Asked Questions

What is Ginkgo Bioworks Holdings Inc(DNA)'s stock price today?
The current price of DNA is $7.00. The 52 week high of DNA is $48.00 and 52 week low is $5.26.
When is next earnings date of Ginkgo Bioworks Holdings Inc(DNA)?
The next earnings date of Ginkgo Bioworks Holdings Inc(DNA) is 2025-05-09 Est..
Does Ginkgo Bioworks Holdings Inc(DNA) pay dividends? If so, how much?
Ginkgo Bioworks Holdings Inc(DNA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1